Xue et al. found in their study that HOTAIR promoted the resistance of ER-positive breast cancer to tamoxifen by up-regulating its expression in ER+ breast cancer patients 48, it is suggested that HOTAIR may be a useful biomarker and a potential therapeutic target. The gene discussed is HOTAIR; the disease is breast cancer.